Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis

REFERENCES

1. 1.↵
   1. Tektonidou MG,
   2. Dasgupta A,
   3. Ward MM.

   Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol 2016;68:1432-41.

   OpenUrl
2. 2.↵
   1. Lee PT,
   2. Fang HC,
   3. Chen CL,
   4. Chiou YH,
   5. Chou KJ,
   6. Chung HM.

   Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus 2003;12:827-32.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hochberg MC.

   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Weening JJ,
   2. D’Agati VD,
   3. Schwartz MM,
   4. Seshan SV,
   5. Alpers CE,
   6. Appel GB, et al.

   The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Maroz N,
   2. Segal MS.

   Lupus nephritis and end-stage kidney disease. Am J Med Sci 2013;346:319-23.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Schwimmer JA,
   2. Markowitz GS,
   3. Valeri A,
   4. Appel GB.

   Collapsing glomerulopathy. Semin Nephrol 2003;23:209-18.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Detwiler RK,
   2. Falk RJ,
   3. Hogan SL,
   4. Jennette JC.

   Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994;45:1416-24.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Albaqumi M,
   2. Soos TJ,
   3. Barisoni L,
   4. Nelson PJ.

   Collapsing glomerulopathy. J Am Soc Nephrol 2006;17:2854-63.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Abadeer K,
   2. Alsaad AA,
   3. Geiger XJ,
   4. Porter IE.

   Collapsing glomerulopathy in systemic lupus erythematosus. BMJ Case Rep 2017;2017:bcr2016217840.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Li CH,
    2. Li YC,
    3. Xu PS,
    4. Hu X,
    5. Wang CY,
    6. Zou GL.

    Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis. Scand J Rheumatol 2006;35:201-8.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Yadla M,
    2. Krishnakishore C,
    3. Reddy S,
    4. Naveen PS,
    5. Sainaresh VV,
    6. Reddy MK, et al.

    An unusual association of anti-GBM diseases and lupus nephritis presenting as pulmonary renal syndrome. Saudi J Kidney Dis Transplant 2011;22:349-51.

    OpenUrl
12. 12.↵
    1. Li C,
    2. Yap DYH,
    3. Chan G,
    4. Wen YB,
    5. Li H,
    6. Tang C, et al.

    Clinical outcomes and clinico-pathological correlations in lupus nephritis with kidney biopsy showing thrombotic microangiopathy. J Rheumatol 2019;46:1478-84.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Sciascia S,
    2. Yazdany J,
    3. Dall’Era M,
    4. Fenoglio R,
    5. Radin M,
    6. Aggarwal I, et al.

    Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. Ann Rheum Dis 2019;78:1004-6.

    OpenUrlFREE Full Text
14. 14.↵
    1. Park MH,
    2. Caselman N,
    3. Ulmer S,
    4. Weitz IC.

    Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv 2018;2:2090-4.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Wilson PC,
    2. Kashgarian M,
    3. Moeckel G.

    Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis. Clin Kidney J 2018;11:207-18.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Lee CJ,
    2. Suh KS,
    3. Kim KH,
    4. Chang YK,
    5. Na KR,
    6. Lee KW.

    The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases. Ultrastruct Pathol 2013;37:386-94.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Kfoury H.

    Tubulo-reticular inclusions in lupus nephritis: are they relevant? Saudi J Kidney Dis Transplant 2014;25:539-43.

    OpenUrl
18. 18.↵
    1. Mehat P,
    2. Atiquzzaman M,
    3. Esdaile JM,
    4. Aviña-Zubieta A,
    5. De Vera MA.

    Medication non-adherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res 2017;69:1706-13.

    OpenUrl
19. 19.↵
    1. Bruce IN,
    2. Gladman DD,
    3. Urowitz MB.

    Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res 2000;13:406-8.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Freedman BI,
    2. Langefeld CD,
    3. Andringa KK,
    4. Croker JA,
    5. Williams AH,
    6. Garner NE, et al.

    End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 2014;66:390-6.

    OpenUrl